Bio-Techne Corp

Common Name
Bio-Techne
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
3,100
Ticker
TECH
Exchange
NASDAQ/NGS
Description
Bio-Techne Corporation is a leading developer and manufacturer of high-quality biological products and solutions for the research and clinical diagnostic markets. The company specializes in providing ...

Financial Statements of Bio-Techne

Below are the financial statements of Bio-Techne, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in millions of USD20252024
Current assets
Cash and cash equivalents
162.19b
151.79b
Short-term available-for-sale investments
0b
1.07b
Accounts receivable, less allowances
206.88b
241.39b
Inventories
189.45b
179.73b
Current assets held-for-sale
12.33b
9.77b
Other current assets
37.46b
33.66b
Total current assets
608.3b
617.42b
Assets
Property and equipment, net
245.72b
251.15b
Right-of-use assets
73.4b
91.29b
Goodwill
980.94b
972.66b
Intangible assets, net
365.6b
507.08b
Deferred tax asset
10.31b
0b
Other assets
273.61b
264.27b
Total assets
2,557.87b
2,703.87b
Current liabilities
Trade accounts payable
25.31b
37.97b
Salaries, wages and related accruals
65.79b
49.82b
Accrued expenses
25.66b
24.89b
Contract liabilities
32.57b
27.93b
Income taxes payable
10.77b
3.71b
Operating lease liabilities - current
14.1b
12.92b
Other current liabilities
1.65b
2.15b
Total current liabilities
175.85b
159.38b
Liabilities and shareholders’ equity
Deferred income taxes
6.17b
55.86b
Long-term debt obligations
346b
319b
Operating lease liabilities
83.96b
87.62b
Other long-term liabilities
27.08b
13.16b
Shareholders’ equity
Undesignated capital stock
0b
0b
Common stock
1.55b
1.58b
Additional paid-in capital
911.09b
820.34b
Retained earnings
1,066.05b
1,325.25b
Accumulated other comprehensive loss
-59.88b
-78.32b
Total shareholders’ equity
1,918.81b
2,068.85b
Total liabilities and shareholders’ equity
2,557.87b
2,703.87b

Verified Sources Behind Bio-Techne’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Bio-Techne’s data sources below and access millions more through our Disclosure Search.

a. Bio-Techne's Annual Report 2025
Trace every data point back to Bio-Techne’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

b. Bio-Techne's 10-K 2025
Trace every data point back to Bio-Techne’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?